-transparent.png){kind=logo}
Thirteen patients with primary hyperparathyroidism were treated for 4-8 weeks with the H2-blocker cimetidine at a daily dose of 1 g. The drug had no effect on the serum concentrations of calcium or parathyroid hormone, nor did any of the patients improve clinically during the period of treatment. The recently reported efficacy of cimetidine in primary hyperparathyroidism is strongly questioned by the present results.
Related Publications
A Kristoffersson, and
S Dahlgren, and
J Järhult, and
L Wählby
March 1980,
Lancet (London, England),
A Kristoffersson, and
S Dahlgren, and
J Järhult, and
L Wählby
November 1982,
British journal of clinical pharmacology,
A Kristoffersson, and
S Dahlgren, and
J Järhult, and
L Wählby
March 1984,
Presse medicale (Paris, France : 1983),
A Kristoffersson, and
S Dahlgren, and
J Järhult, and
L Wählby
April 1981,
Postgraduate medical journal,
A Kristoffersson, and
S Dahlgren, and
J Järhult, and
L Wählby
July 1974,
The Journal of clinical investigation,
A Kristoffersson, and
S Dahlgren, and
J Järhult, and
L Wählby
January 1989,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
A Kristoffersson, and
S Dahlgren, and
J Järhult, and
L Wählby
January 1979,
The New England journal of medicine,
A Kristoffersson, and
S Dahlgren, and
J Järhult, and
L Wählby
July 1981,
La Clinica terapeutica,
A Kristoffersson, and
S Dahlgren, and
J Järhult, and
L Wählby
December 1978,
The Journal of clinical endocrinology and metabolism,
A Kristoffersson, and
S Dahlgren, and
J Järhult, and
L Wählby
February 1990,
The British journal of surgery,
